8RNU image
Entry Detail
PDB ID:
8RNU
EMDB ID:
Keywords:
Title:
CryoEM structure of recombinant human Bri2 BRICHOS oligomers
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2024-01-11
Release Date:
2024-06-19
Method Details:
Experimental Method:
Resolution:
3.40 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Integral membrane protein 2B
Chain IDs:A, B (auth: K), C (auth: E), D (auth: I), E (auth: C), F (auth: G), G (auth: B), H, I (auth: D), J, K (auth: F), L
Chain Length:119
Number of Molecules:12
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Molecular basis for different substrate-binding sites and chaperone functions of the BRICHOS domain.
Protein Sci. 33 e5063 e5063 (2024)
PMID: 38864729 DOI: 10.1002/pro.5063

Abstact

Proteins can misfold into fibrillar or amorphous aggregates and molecular chaperones act as crucial guardians against these undesirable processes. The BRICHOS chaperone domain, found in several otherwise unrelated proproteins that contain amyloidogenic regions, effectively inhibits amyloid formation and toxicity but can in some cases also prevent non-fibrillar, amorphous protein aggregation. Here, we elucidate the molecular basis behind the multifaceted chaperone activities of the BRICHOS domain from the Bri2 proprotein. High-confidence AlphaFold2 and RoseTTAFold predictions suggest that the intramolecular amyloidogenic region (Bri23) is part of the hydrophobic core of the proprotein, where it occupies the proposed amyloid binding site, explaining the markedly reduced ability of the proprotein to prevent an exogenous amyloidogenic peptide from aggregating. However, the BRICHOS-Bri23 complex maintains its ability to form large polydisperse oligomers that prevent amorphous protein aggregation. A cryo-EM-derived model of the Bri2 BRICHOS oligomer is compatible with surface-exposed hydrophobic motifs that get exposed and come together during oligomerization, explaining its effects against amorphous aggregation. These findings provide a molecular basis for the BRICHOS chaperone domain function, where distinct surfaces are employed against different forms of protein aggregation.

Legend

Protein

Chemical

Disease

Primary Citation of related structures